← Open Payments lookup

GWENDOLYN LA CROIX: Open Payments

NPI 1801343942 · MILAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,010 in 33 payments from 9 companies in 2025. Trend: 2023 $1,272 · 2024 $1,265 · 2025 $1,010

Food & beverage: $1,010
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.13$342
Lundbeck LLC10$291
ABBVIE INC.2$172
Supernus Pharmaceuticals, Inc.1$85
E.R. Squibb & Sons, L.L.C.2$39
Takeda Pharmaceuticals U.S.A., Inc.2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$15
Teva Pharmaceuticals USA, Inc.1$14
Neurocrine BioSciences, Inc.1$14

Products named: REXULTI, HETLIOZ, VRAYLAR, FANAPT, Qelbree, COBENFY, TRINTELLIX, CAPLYTA.

Industry payments across MI — which companies pay providers there.